Hypohomocysteinemia: A Potentially Treatable Cause of Peripheral Neuropathology?

Physical Medicine and Rehabilitation Clinics of North America

Volumn 23, Issue 1, 2012, Pages 59-65

  Cullen, Clark E ^a,b   Carter, Gregory T ^c   Weiss, Michael D ^d   Grant, Peter A ^b   Saperstein, David Scott ^e  

^a Sunstone Medical Research   (United States)

^b Regional Neuromuscular Center ^*  (United States)

^c Regional Neuromuscular Center   (United States)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^e Phoenix Neurological Associates   (United States)

Author keywords

Folate; Homocysteine deficiency; Hypohomocysteinemia; Neuromuscular disease; Nutrition; Peripheral neuropathy

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; HOMOCYSTEINE; METHIONINE; S ADENOSYLMETHIONINE;

ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; AGED; AMINO ACID BLOOD LEVEL; ARM WEAKNESS; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; ELECTRODIAGNOSIS; EVOKED SOMATOSENSORY RESPONSE; FEMALE; GENE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HYPOHOMOCYSTEINEMIA; LATENT PERIOD; LIMB WEAKNESS; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; MUSCLE ATROPHY; NERVE POTENTIAL; NEUROPATHOLOGY; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REFLEX DISORDER; REVIEW;

EID: 84855736542     PISSN: 10479651     EISSN: 15581381     Source Type: Journal    
DOI: 10.1016/j.pmr.2011.11.001     Document Type: Review

References (32)

1. Postiglione A., Milan G., Ruocco A., et al. Plasma folate, vitamin B-12, and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study. Gerontology 2001, 47(6):324-329.
2. Oussalah A., Guéant J.L., Peyrin-Biroulet L. Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases. Aliment Pharmacol Ther 2011, 34(10):1173-1184.
3. Metz J. Cobalamin deficiency and the pathogenesis of nervous system disease. Annu Rev Nutr 1992, 12:59-79.
4. Mischoulon D., Raab M.F. The role of folate in depression and dementia. JClin Psychiatry 2007, 68(Suppl 10):28-33.
5. Anello G., Guéant-Rodríguez R.M., Bosco P., et al. Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. Neuroreport 2004, 15(5):859-861.
6. Bottiglieri T., Hyland K., Reynolds E.H. The clinical potential of admetionine (S-adenosylmethionine) in neurologic disorders. Drugs 1994, 48(2):137-152.
7. Smith D.A., Smith S.M., de Jager C.A., et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One 2010, 5(9):e12244.
8. Bottiglieri T. Homocysteine and folate metabolism in depression. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:1103-1112.
9. Morris S.A., Jacques P.F. Folate and neurologic function: epidemiologic perspective. Folate in health and disease 2010, 330-333. Taylor and Francis Group, Boca Raton (FL). L.B. Bailey (Ed.).
10. Zhou Y.H., Tang J.Y., Wu M.J., et al. Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis. PLoS One 2011, 6(9):e25142.
11. Martí-Carvajal A.J., Solà I., Lathyris D., et al. Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev 2009, 4. CD006612.
12. van Guldener C., Stehouwer C.D. Homocysteine-lowering treatment: an overview. Expert Opin Pharmacother 2001, 2(9):1449-1460.
13. Albert C.M., Cook N.R., Gaziano J.M., et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA 2008, 299(17):2027-2036.
14. Selhub J. Public health significance of elevated homocysteine. Food Nutr Bull 2008, 29(Suppl 2):S116-S125.
15. Bottiglieri T., Reynolds E. Folate and neurologic disease: basic mechanisms. Folate in health and disease 2010, 355-380. Taylor and Francis Group, LLC; CRC Press, Boca Raton (FL). L. Bailey (Ed.).
16. Batey R.T. Recognition of S-adenosylmethionine by riboswitches. Wiley Interdiscip Rev RNA 2011, 2(2):299-311.
17. Iskandar B.J., Rizk E., Meier B., et al. Folate regulation of axonal regeneration in the rodent central nervous system through DNA methylation. JClin Invest 2010, 120(5):1603-1616.
18. Lawrance A.K., Racine J., Deng L., et al. Complete deficiency of methylenetetrahydrofolate reductase in mice is associated with impaired retinal function and variable mortality, hematological profiles, and reproductive outcomes. JInherit Metab Dis 2011, 34(1):147-157.
19. Leclerc D., Rozen R. Molecular genetics of MTHFR: polymorphisms are not all benign. Med Sci (Paris) 2007, 23(3):297-302.
20. Rummel T., Suormala T., Häberle J., et al. Intermediate hyperhomocysteinaemia and compound heterozygosity for the common variant c.677C>T and a MTHFR gene mutation. JInherit Metab Dis 2007, 30(3):401.
21. Bosy-Westphal A., Holzapfel A., Czech N., et al. Plasma folate but not vitamin B(12) or homocysteine concentrations are reduced after short-term vitamin B(6) supplementation. Ann Nutr Metab 2001, 45(6):255-258.
22. Hoffman M. Hypothesis: hyperhomocysteinemia is an indicator of oxidant stress. Med Hypotheses 2011, 77(6):1088-1093.
23. Bader N., Bosy-Westphal A., Koch A., et al. Influence of vitamin C and E supplementation on oxidative stress induced by hyperbaric oxygen in healthy men. Ann Nutr Metab 2006, 50(3):173-176.
24. Smulders Y.M., Smith D.E., Kok R.M., et al. Cellular folate vitamer distribution during and after correction of vitamin B12 deficiency: a case for the methylfolate trap. Br J Haematol 2006, 132(5):623-629.
25. Aoyama K., Suh S.W., Hamby A.M., et al. Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat Neurosci 2005, 9:119-126.
26. Bird A. Putting the DNA back into DNA methylation. Nat Genet 2011, 43(11):1050-1051.
27. Watkins D., Ru M., Hwang H.Y., et al. Hyperhomocysteinemia due to methionine synthase deficiency, cblG structure of the MTR gene, genotype diversity, and recognition of a common mutation, p1173L. Am J Hum Genet 2002, 71:143-153.
28. Ukinc K., Ersoz H.O., Karahan C., et al. Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy. Endocrine 2009, 36(2):255-261.
29. Walker M.J. Jr, Morris L.M., Cheng D. Improvement of cutaneous sensitivity in diabetic peripheral neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5'-phosphate. Rev Neurol Dis 2010, 7(4):132-139.
30. Ginsberg L.D., Oubre A.Y., Daoud Y.A. L-methylfolate plus SSRI or SNRI from treatment initiation compared to SSRI or SNRI monotherapy in a major depressive episode. Innov Clin Neurosci 2011, 8(1):19-28.
31. Bottiglieri T., Laundy M., Crellin R., et al. Homocysteine, folate, methylation, and monoamine metabolism in depression. JNeurol Neurosurg Psychiatry 2000, 69:228-232.
32. Head S.I., Greenaway B., Chan S. Incubating isolated mouse EDL muscles with creatine improves force production and twitch kinetics in fatigue due to reduction in ionic strength. PLoS One 2011, 6(8):e22742.